Institutional members access full text with Ovid®

Share this article on:

The Role of Laparoscopy in Ovarian Tumors of Low Malignant Potential and Early-Stage Ovarian Cancer

Vaisbuch, Edi MD*; Dgani, Ram MD; Ben-Arie, Alon MD; Hagay, Zion MD§

Obstetrical & Gynecological Survey: May 2005 - Volume 60 - Issue 5 - p 326-330
doi: 10.1097/01.ogx.0000161373.94922.33

Although it is feasible today to perform laparoscopic surgical staging and treatment of ovarian low malignant potential tumors and early-stage ovarian cancer safely, it is still generally agreed that a patient with ovarian cancer should have a laparotomy. Concerns related to laparoscopy in managing gynecologic malignancy include the accuracy of intraoperative diagnosis, inadequate resection, significance of tumor spillage, improper or delay in surgical staging, delay in therapy, and the possibility of port-site metastasis. On the other hand, laparoscopy has the advantages of being a minimally invasive surgery, with shorter hospitalization, decreased postoperative pain, and quicker return to normal daily activities. We review the current literature discussing the consequences of laparoscopic surgery in ovarian tumors of low malignant potential and early-stage ovarian cancer.

Target Audience: Obstetricians & Gynecologists, Family Physicians

Learning Objectives: After completion of this article, the reader should be able to list the concerns related to laparoscopic management of ovarian malignancies, to outline the accuracy of the diagnosis of low malignant potential (LMP) ovarian tumors on frozen section, and to summarize the data on the effect of capsule rupture on overall prognosis for patients with ovarian cancer.

*Resident, Department of Obstetrics and Gynecology; †Head, Gynecological-Oncology Service; ‡Head, Department of Obstetrics and Gynecology; and §Lecturer, Department of Obstetrics and Gynecology, Kaplan Medical Center, associated with the School of Medicine, Hebrew University and Hadassah, Jerusalem, Israel

Chief Editor’s Note: This article is part of a series of continuing education activities in this Journal through which a total of 36 AMA/PRA category 1 credit hours can be earned in 2005. Instructions for how CME credits can be earned appear on the last page of the Table of Contents.

The authors have disclosed that they have no financial relationships with or interests in any commercial companies pertaining to this educational activity.

Reprint requests to: Edi Vaisbuch, MD, Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, 76100, Israel E-mail: or

© 2005 Lippincott Williams & Wilkins, Inc.